Recent studies have shown that the chemokine receptor CCR8 is overexpressed in tumor-infiltrating Tregs of patients with different cancers, including breast, colon, and lung cancers, with no major CCR8-positivity found on peripheral Tregs [5–7]. This evidence concerns the gene CCR8 and lung carcinoma.